Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Colorcon
Baxter
Harvard Business School
McKesson
Medtronic
Citi
Accenture
Merck

Generated: December 9, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ABALOPARATIDE

« Back to Dashboard

Clinical Trials for Abaloparatide

Trial ID Title Status Sponsor Phase Summary
NCT01343004 Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women Completed Radius Health, Inc. Phase 3 The purpose of this study is to determine whether BA058 (abaloparatide), a parathyroid hormone-related peptide, is effective in preventing fractures in postmenopausal women with severe osteoporosis who are at risk of fractures.
NCT01657162 Twenty Four Month Extension Study of BA058-05-003 Active, not recruiting Radius Health, Inc. Phase 3 The purpose of this study is to provide 24 months of standard of care data on subjects previously enrolled in study BA058-05-003.
NCT01674621 Phase 2 Study of BA058 (Abaloparatide) Transdermal Delivery in Postmenopausal Women With Osteoporosis Completed Nordic Bioscience A/S Phase 2 To determine the clinical safety and efficacy of BA058 Transdermal in otherwise healthy postmenopausal women with osteoporosis as assessed by changes in bone mineral density (BMD) and serum markers of bone metabolism when compared to Transdermal Placebo and BA058 Injection for 6 months of treatment.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Abaloparatide

Condition Name

Condition Name for Abaloparatide
Intervention Trials
Osteoporosis 4
Osteoporosis of Vertebrae 2
Osteoporosis Localized to Spine 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Abaloparatide
Intervention Trials
Osteoporosis 6
Osteoporosis, Postmenopausal 5
Osteoporotic Fractures 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Abaloparatide

Trials by Country

Trials by Country for Abaloparatide
Location Trials
United States 14
Denmark 3
Estonia 3
Poland 3
Argentina 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Abaloparatide
Location Trials
Maryland 4
Georgia 3
Colorado 3
Massachusetts 2
Florida 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Abaloparatide

Clinical Trial Phase

Clinical Trial Phase for Abaloparatide
Clinical Trial Phase Trials
Phase 4 1
Phase 3 4
Phase 2 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Abaloparatide
Clinical Trial Phase Trials
Completed 2
Not yet recruiting 2
Recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Abaloparatide

Sponsor Name

Sponsor Name for Abaloparatide
Sponsor Trials
Radius Health, Inc. 5
Nordic Bioscience A/S 1
Johns Hopkins University 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Abaloparatide
Sponsor Trials
Industry 6
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Federal Trade Commission
Queensland Health
UBS
Harvard Business School
Daiichi Sankyo
Accenture
AstraZeneca
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.